150 related articles for article (PubMed ID: 30350532)
1. The role of the pathologist and clinical implications in colorectal liver metastasis.
Baldin P; Van den Eynde M; Hubert C; Jouret-Mourin A; Komuta M
Acta Gastroenterol Belg; 2018; 81(3):419-426. PubMed ID: 30350532
[TBL] [Abstract][Full Text] [Related]
2. Morphological aspects of the hepatic response to neoadjuvant therapy.
Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
[TBL] [Abstract][Full Text] [Related]
3. Impact of novel histopathological factors on the outcomes of liver surgery for colorectal cancer metastases.
Serrablo A; Paliogiannis P; Pulighe F; Moro SS; Borrego-Estella V; Attene F; Scognamillo F; Hörndler C
Eur J Surg Oncol; 2016 Sep; 42(9):1268-77. PubMed ID: 26947960
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.
Passot G; Chun YS; Kopetz SE; Overman MJ; Conrad C; Aloia TA; Vauthey JN
Eur J Surg Oncol; 2016 Sep; 42(9):1378-84. PubMed ID: 27358198
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of
Shim JR; Lee SD; Han SS; Lee SJ; Lee DE; Kim SK; Kim SH; Park SJ; Oh JH
Eur J Surg Oncol; 2018 May; 44(5):670-676. PubMed ID: 29459018
[TBL] [Abstract][Full Text] [Related]
6. Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM).
Saez-Carlin P; García-Botella A; Diez-Valladares LI; Ortega Medina L; Méndez R; González JCM; Bernal I; Serrano García I; Avellana R; Torres García AJ
Clin Transl Oncol; 2020 Jul; 22(7):1180-1186. PubMed ID: 31758496
[TBL] [Abstract][Full Text] [Related]
7. Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore.
Baldin P; Van den Eynde M; Mlecnik B; Bindea G; Beniuga G; Carrasco J; Haicheur N; Marliot F; Lafontaine L; Fredriksen T; Lanthier N; Hubert C; Navez B; Huyghe N; Pagès F; Jouret-Mourin A; Galon J; Komuta M
J Pathol Clin Res; 2021 Jan; 7(1):27-41. PubMed ID: 32902189
[TBL] [Abstract][Full Text] [Related]
8. High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases.
Strowitzki MJ; Radhakrishnan P; Pavicevic S; Scheer J; Kimmer G; Ritter AS; Tuffs C; Volz C; Vondran F; Harnoss JM; Klose J; Schmidt T; Schneider M
Br J Cancer; 2019 Apr; 120(7):675-688. PubMed ID: 30808993
[TBL] [Abstract][Full Text] [Related]
9. BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy.
Teng HW; Huang YC; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Wang HW; Chang SC; Lan YT; Lin CC; Wang HS; Yang SH
J Surg Oncol; 2012 Aug; 106(2):123-9. PubMed ID: 22331825
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
[TBL] [Abstract][Full Text] [Related]
11. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.
Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T
J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994
[TBL] [Abstract][Full Text] [Related]
12. PARAGON II - A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer.
Jones RP; Malik HZ; Fenwick SW; Terlizzo M; O'Grady E; Stremitzer S; Gruenberger T; Rees M; Plant G; Figueras J; Albiol M; Adam R; Awad S; Poston GJ
Eur J Surg Oncol; 2016 Dec; 42(12):1866-1872. PubMed ID: 27561844
[TBL] [Abstract][Full Text] [Related]
13. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
[TBL] [Abstract][Full Text] [Related]
14. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?
Ihnát P; Vávra P; Zonča P
World J Gastroenterol; 2015 Jun; 21(22):7014-21. PubMed ID: 26078580
[TBL] [Abstract][Full Text] [Related]
15. Impact of chemotherapy-associated liver injury on tumour regression grade and survival in patients with colorectal liver metastases.
Zhao J; Sawo P; Rensen SS; Rouflart MMJ; Winstanley A; Vreuls CPH; Verheij J; van Mierlo KMC; Lodewick TM; van Woerden V; van Tiel FH; van Dam RM; Dejong CHC; Olde Damink SWM
HPB (Oxford); 2018 Feb; 20(2):147-154. PubMed ID: 28969959
[TBL] [Abstract][Full Text] [Related]
16. Optimizing management of colorectal hepatic metastases: now and in the future.
Uppal A; Weichselbaum RR; Posner MC
Eur J Surg Oncol; 2014 Sep; 40(9):1033-5. PubMed ID: 24703655
[No Abstract] [Full Text] [Related]
17. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
[TBL] [Abstract][Full Text] [Related]
18. Gene mutation and surgical technique: Suggestion or more?
Kawaguchi Y; Lillemoe HA; Vauthey JN
Surg Oncol; 2020 Jun; 33():210-215. PubMed ID: 31351766
[TBL] [Abstract][Full Text] [Related]
19. KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma.
Siyar Ekinci A; Demirci U; Cakmak Oksuzoglu B; Ozturk A; Esbah O; Ozatli T; Celik B; Budakoglu B; Turker I; Bal O; Turan N
J BUON; 2015; 20(1):128-35. PubMed ID: 25778307
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study.
Javed S; Benoist S; Devos P; Truant S; Guimbaud R; Lièvre A; Sefrioui D; Cohen R; Artru P; Dupré A; Bachet JB; de la Fouchardière C; Ploquin A; Turpin A
World J Surg Oncol; 2022 Apr; 20(1):131. PubMed ID: 35461290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
